Green Security? General Mills well-positioned in tough environment, says Piper Sandler 16:00 GIS Piper Sandler analyst Michael Lavery believes General Mills is well-positioned in his large cap food coverage to continue to manage inflation headwinds. While the analyst expects continued pressure from inflation, he thinks pricing and productivity can mitigate headwinds. General Mills expects to cover inflation with pricing and savings by Q2 of 2022, slightly ahead of what Lavery currently models. Pet category momentum remains elevated, with the company looking well-positioned there, the analyst contends, adding that he believes his Pet estimates may still be conservative. Lavery has an Overweight rating and a price target of $70 on the shares You know Van my dog's poops have been not good lately. Mealy mounds not logs. I wonder if GIS did mess with the Blue Buff food that's what he eats....
Van I came very close today to buying but tomorrow is almost here will you join me? GENI Genius Sports Limited is highlighted by Benchmark for its 60% upside potential Genius Sports Limited (GENI+1.6%) is higher after Benchmark reiterated a Buy rating on the stock with a view that the sports betting market will grow by more than 20X. Analyst Mike Hickey: "The U.S. sports betting is anticipated to expand from a $1B in FY19 to a $23B market at maturity. GENI is currently operational in an estimated 15 U.S. states and provides sportsbooks official data, streaming, and marketing solutions... We see potential financial upside from both the increased use of official sports data for in-game betting, data that is sold at a premium, and the continued expansion of the sports betting ecosystem, including innovative market solutions for user acquisition." Running the numbers, Benchmark sees $1.2B in revenue for GENI and $500M in AEBITDA off a 40% long-term AEBITDA margin rate. The firm's price target on Genius Sports(NYSE:GENI)is $33 to rep more than 60% upside potential. GENI has a clean sweep of six bull ratings on Wall Street with no doubters on record.
Van has ZS in this portfolio. That's a good one. I had CRWD & MIME but sold both. Pricey. I would like to look less at ransom ware and maybe more at Crypto security? I wonder if there is a leader in that space? It seems like you can wake up and your digital wallet has been gone through.
I just did my Savant thing and two names popped in. 1) Double Verify DV & 2) WKEY Description WISeKey International Holding AG, a cybersecurity company, provides integrated security solutions for the Internet of Things (IoT) and digital identity ecosystems in Switzerland, rest of Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company operates through two segments, IoT and mPKI. It offers microcontrollers that provides identity to various connected devices; and managed public key infrastructure (PKI), which include digital identity, certificate management and signing solutions, and trust services, as well as offers digital certificates; software as a service (SaaS), including cloud-based certificate life-cycle-management and signing and authentication solutions; software licenses; post-contract customer support for cybersecurity applications; and infrastructure hosting and monitoring services. The company also develops, markets, hosts, and supports a range of solutions that enable secure digital identification of people, content, and objects by generating digital identities through its products and services in cybersecurity services, IoT, digital brand management, and mobile security, which enable clients to monetize their existing user bases, as well as expand its eco-system. In addition, the company operates ISTANA platform to manage components in an intelligent car by providing digital identities based on PKI technology.; and engages in financing, sales, and distribution activities. WISeKey International Holding AG has strategic partnership agreements with Turing Crypto GmbH to offer a suite of SSL/TLS services in the Asia-Pacific region; and CasperLabs Networks AG to provide a marketplace on the Casper Network for buying and selling non-fungible tokens, including artwork and luxury goods. The company was founded in 1999 and is headquartered in Zug, Switzerland.
I think I told you this before. DV has to get thru lockup. Just like MQ. Both good stocks however. Anybody's guess at the present time.
Keep an eye on volcanic activity. Here is a 30 min video which might introduce some different ideas such as the alleged approaching grand solar minimum.
American Campus price target raised to $58 from $51 at Deutsche Bank 06:34 ACC Deutsche Bank analyst Derek Johnston raised the firm's price target on American Campus to $58 from $51 and keeps a Buy rating on the shares. A key theme emerging from residential real estate investment trust's Q2 earnings calls was that management teams are encouraged by accelerating demand as we move past the disruptions created by the pandemic, Johnston tells investors in a research note. Residential REITs are now "sun setting a majority of leases" which were signed in the early innings of the virus, leading to improved operating metrics given better than feared leasing activity, says the analyst. Van I think this double bottomed @ $48 and could break a downtrend here- This is going to $54-$55 w a 3% div. Is it enough? How To Make A Gummy A) Find an incurable disease- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) disorders B) Have some recent conferences that get people excited Anavex Life Sciences to Present at the 2021 Cantor Virtual Global Healthcare Conference The conference is being held September 27-30, 2021. C) Have some mysterious upgrade for no reason Anavex initiated with a Buy at BTIG 06:42 AVXL D) Have a goodproduct The pipeline Anavex conducts clinical trials for its small molecules, Anavex 2-73 (blarcamesine) and Anavex 3-71 (AF710B), for slowing the progression of Alzheimer's disease. In addition, the therapies being developed are intended to treat other neurodegenerative and neurodevelopmental disorders, such as Rett syndrome and Parkinson's disease as well as other central nervous system diseases. E) Have cash in the bank The finances The biotech had cash and equivalents of approximately $75.9 million as at March 31, 2021, sufficient to last for up tothreeyears, according to its CEO. Now, Anavex does not generate revenues and has to resort to equity offerings to finance operations. F) Have a muted open. + 2.5% G) Be well off it's high 52 week high of $31 SHALL WE TRY OUR HAND AT A GUMMY? Anavex Life Sciences Corp. (AVXL) NasdaqCM - NasdaqCM Real Time Price. Currency in USD 17.64+0.24 (+1.38%) At close: September 22 4:00PM EDT 18.10+0.46 (2.61%)<------------------ Pre-Market:06:36AM EDT Booooooooooooo! A) Salesforce Chairman Marc Benioff sells over $5M in company shares 17:36 CRM Salesforce Chairman Marc Benioff disclosed in a filing that he had sold 20,000 shares of company stock at $259.60 per share on September 21, for a total transaction value of $5,191,902. B) Genius Sports files to sell 6.625M ordinary shares for holders 17:12 GENI